| 1 |
34407041 |
10.1097/CAD.0000000000001165 |
2022 |
Risk-tailored treatment of splenic marginal zone lymphoma. |
NOTCH2 |
| 2 |
34435359 |
10.1111/imm.13408 |
2022 |
LncRNA00492 is required for marginal zone B-cell development. |
NOTCH2 |
| 3 |
34494161 |
10.1007/s00428-021-03186-3 |
2022 |
Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin. |
NOTCH2 |
| 4 |
34586000 |
10.1080/10428194.2021.1984452 |
2022 |
NOTCH signaling in the pathogenesis of splenic marginal zone lymphoma-opportunities for therapy. |
NOTCH2 |
| 5 |
34632572 |
10.1111/bjh.17858 |
2022 |
Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma. |
NOTCH2 |
| 6 |
34821038 |
10.1111/ijlh.13769 |
2022 |
T cell lymphoblastic lymphoma with uncommon CD20 expression. |
NOTCH2 |
| 7 |
35236331 |
10.1186/s12885-022-09237-5 |
2022 |
Prognostic mutational subtyping in de novo diffuse large B-cell lymphoma. |
NOTCH2 |
| 8 |
35317330 |
10.14740/wjon1436 |
2022 |
Non-GCB Diffuse Large B-Cell Lymphoma With an Atypical Disease Course: A Case Report and Clinical Exome Analysis. |
NOTCH2 |
| 9 |
35339566 |
10.1016/j.humpath.2022.03.008 |
2022 |
Myeloid nuclear differentiation antigen: an aid in differentiating lymphoplasmacytic lymphoma and splenic marginal zone lymphoma in bone marrow biopsies at presentation. |
NOTCH2 |
| 10 |
35834399 |
10.1097/PAS.0000000000001932 |
2022 |
Pediatric-Type Indolent B-Cell Lymphomas With Overlapping Clinical, Pathologic, and Genetic Features. |
NOTCH2 |
| 11 |
35964234 |
10.1093/ajcp/aqac087 |
2022 |
Histiocytic Sarcoma With CCND1 Gene Rearrangement Clonally Related and Transdifferentiated From Mantle Cell Lymphoma. |
NOTCH2 |
| 12 |
35967131 |
10.7759/cureus.26738 |
2022 |
Splenic Marginal Zone Lymphoma With Histological Transformation to Hodgkin's Lymphoma. |
NOTCH2 |
| 13 |
32273478 |
10.3324/haematol.2020.251579 |
2021 |
Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma. |
NOTCH2 |
| 14 |
33111346 |
10.1002/jcp.30115 |
2021 |
PTN-PTPRZ signalling is involved in deer antler stem cell regulation during tissue regeneration. |
NOTCH2 |
| 15 |
33311649 |
10.1038/s41379-020-00720-7 |
2021 |
Targeted massively parallel sequencing of mature lymphoid neoplasms: assessment of empirical application and diagnostic utility in routine clinical practice. |
NOTCH2 |
| 16 |
33314017 |
10.1111/bjh.17141 |
2021 |
Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities. |
NOTCH2 |
| 17 |
33570635 |
10.1182/bloodadvances.2020002995 |
2021 |
Notch activation is pervasive in SMZL and uncommon in DLBCL: implications for Notch signaling in B-cell tumors. |
NOTCH2 |
| 18 |
34039950 |
10.1038/s41408-021-00493-5 |
2021 |
Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing. |
NOTCH2 |
| 19 |
34204385 |
10.3390/cancers13123032 |
2021 |
Cell-Free Total Nucleic Acid-Based Genotyping of Aggressive Lymphoma: Comprehensive Analysis of Gene Fusions and Nucleotide Variants by Next-Generation Sequencing. |
NOTCH2 |
| 20 |
34299796 |
10.3390/ijerph18147345 |
2021 |
The Genomic Landscape of a Restricted ALL Cohort from Patients Residing on the U.S./Mexico Border. |
NOTCH2 |
| 21 |
34378195 |
10.1111/bjh.17765 |
2021 |
Genetic subtype classification using a simplified algorithm and mutational characteristics of diffuse large B-cell lymphoma in a Japanese cohort. |
NOTCH2 |
| 22 |
35008340 |
10.3390/cancers14010176 |
2021 |
Recent Advances in the Genetic of MALT Lymphomas. |
NOTCH2 |
| 23 |
31433838 |
10.1093/ajcp/aqz133 |
2020 |
An Uncommon Case of Double-Hit Mantle Cell Lymphoma That Demonstrates a Transformation Process. |
NOTCH2 |
| 24 |
31894255 |
10.3892/ijmm.2019.4418 |
2020 |
Precision medicine for human cancers with Notch signaling dysregulation (Review). |
NOTCH2 |
| 25 |
32187361 |
10.1182/blood.2019003535 |
2020 |
Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report. |
NOTCH2 |
| 26 |
32191807 |
10.1182/bloodadvances.2019001396 |
2020 |
Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL. |
NOTCH2 |
| 27 |
32239385 |
10.1007/s11523-020-00710-4 |
2020 |
Genomic Alterations and MYD88<sup>MUT</sup> Variant Mapping in Patients with Diffuse Large B-Cell Lymphoma and Response to Ibrutinib. |
NOTCH2 |
| 28 |
32239765 |
10.1002/ajh.25796 |
2020 |
Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients. |
NOTCH2 |
| 29 |
32277542 |
10.1002/gcc.22849 |
2020 |
Aggressive morphologic variants of mantle cell lymphoma characterized with high genomic instability showing frequent chromothripsis, CDKN2A/B loss, and TP53 mutations: A multi-institutional study. |
NOTCH2 |
| 30 |
32585984 |
10.3390/cancers12061669 |
2020 |
Discovery of Novel Recurrent Mutations and Clinically Meaningful Subgroups in Nodal Marginal Zone Lymphoma. |
NOTCH2 |
| 31 |
32598477 |
10.1182/bloodadvances.2019001350 |
2020 |
Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis. |
NOTCH2 |
| 32 |
32871937 |
10.1097/MD.0000000000021938 |
2020 |
Aggressive variant of splenic marginal zone lymphoma characterized using a cancer panel test and treated with rituximab-containing chemotherapy: A case report. |
NOTCH2 |
| 33 |
33017398 |
10.1371/journal.pbio.3000850 |
2020 |
Notch dimerization and gene dosage are important for normal heart development, intestinal stem cell maintenance, and splenic marginal zone B-cell homeostasis during mite infestation. |
NOTCH2 |
| 34 |
33211828 |
10.1182/bloodadvances.2020002944 |
2020 |
Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease. |
NOTCH2 |
| 35 |
33224395 |
10.14740/jh760 |
2020 |
Molecular Genetic Analysis With Flow Cytometry Sorting Identifies Angioimmunoblastic T-Cell Lymphoma and Concomitant <i>De Novo</i> Myelodysplastic Syndrome Arising From the Same Hematopoietic Progenitor. |
NOTCH2 |
| 36 |
33400727 |
10.18632/oncotarget.27805 |
2020 |
RNA sequencing analyses reveal differentially expressed genes and pathways as Notch2 targets in B-cell lymphoma. |
NOTCH2 |
| 37 |
30802265 |
10.1371/journal.pone.0212813 |
2019 |
Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma. |
NOTCH2 |
| 38 |
30963600 |
10.1002/ajh.25487 |
2019 |
Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management. |
NOTCH2 |
| 39 |
31320741 |
10.1038/s41598-019-46906-1 |
2019 |
Systematic Review of Somatic Mutations in Splenic Marginal Zone Lymphoma. |
NOTCH2 |
| 40 |
31378966 |
10.1002/ajh.25600 |
2019 |
Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network. |
NOTCH2 |
| 41 |
31395597 |
10.1101/mcs.a004259 |
2019 |
Divergent clonal evolution of a common precursor to mantle cell lymphoma and classic Hodgkin lymphoma. |
NOTCH2 |
| 42 |
29641966 |
10.1056/NEJMoa1801445 |
2018 |
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma. |
NOTCH2 |
| 43 |
29735551 |
10.1158/0008-5472.CAN-17-4004 |
2018 |
Novel Richter Syndrome Xenograft Models to Study Genetic Architecture, Biology, and Therapy Responses. |
NOTCH2 |
| 44 |
29755111 |
10.1038/s41417-018-0022-5 |
2018 |
Genomic landscape and prognostic analysis of mantle cell lymphoma. |
NOTCH2 |
| 45 |
29955182 |
10.1038/s41591-018-0097-4 |
2018 |
Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. |
NOTCH2 |
| 46 |
29989027 |
10.18632/oncotarget.25601 |
2018 |
New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes. |
NOTCH2 |
| 47 |
30073422 |
10.1007/s12032-018-1183-7 |
2018 |
Splenic marginal zone lymphomas in acquired C1-inhibitor deficiency: clinical and molecular characterization. |
NOTCH2 |
| 48 |
27347751 |
10.1080/10428194.2016.1196813 |
2017 |
Splenic diffuse red pulp lymphoma has a distinct pattern of somatic mutations amongst B-cell malignancies. |
NOTCH2 |
| 49 |
27717083 |
10.1002/gcc.22423 |
2017 |
T-cell acute lymphoblastic leukemia in infants has distinct genetic and epigenetic features compared to childhood cases. |
NOTCH2 |
| 50 |
27874290 |
10.1080/10428194.2016.1260124 |
2017 |
Impact of clinical factors on outcome of leukemia patients with TLS-ERG fusion gene. |
NOTCH2 |
| 51 |
28232365 |
10.1158/2159-8290.CD-16-1189 |
2017 |
BCL6 Antagonizes NOTCH2 to Maintain Survival of Human Follicular Lymphoma Cells. |
NOTCH2 |
| 52 |
28288718 |
10.1016/j.beha.2016.09.005 |
2017 |
Splenic marginal zone lymphoma. |
NOTCH2 |
| 53 |
28522570 |
10.3324/haematol.2016.161711 |
2017 |
Clinical and diagnostic relevance of <i>NOTCH2</i>-and <i>KLF2</i>-mutations in splenic marginal zone lymphoma. |
NOTCH2 |
| 54 |
26426381 |
10.1097/PAS.0000000000000523 |
2016 |
NOTCH1, TP53, and MAP2K1 Mutations in Splenic Diffuse Red Pulp Small B-cell Lymphoma Are Associated With Progressive Disease. |
NOTCH2 |
| 55 |
26989207 |
10.1182/blood-2015-11-624312 |
2016 |
Splenic marginal zone lymphoma: from genetics to management. |
NOTCH2 |
| 56 |
27121112 |
10.3109/10428194.2016.1173212 |
2016 |
Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets. |
NOTCH2 |
| 57 |
27148583 |
10.1101/mcs.a000679 |
2016 |
Molecular etiology of an indolent lymphoproliferative disorder determined by whole-genome sequencing. |
NOTCH2 |
| 58 |
27248180 |
10.18632/oncotarget.9678 |
2016 |
The genetic landscape of dural marginal zone lymphomas. |
NOTCH2 |
| 59 |
27335277 |
10.1182/blood-2016-02-696757 |
2016 |
The genetics of nodal marginal zone lymphoma. |
NOTCH2 |
| 60 |
27566587 |
10.18632/oncotarget.11548 |
2016 |
Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas. |
NOTCH2 |
| 61 |
27572051 |
10.3892/mmr.2016.5688 |
2016 |
Notch 2 signaling contributes to cell growth, anti-apoptosis and metastasis in laryngeal squamous cell carcinoma. |
NOTCH2 |
| 62 |
25023849 |
10.1016/j.medcli.2014.04.025 |
2015 |
[Mantle cell lymphoma: Towards a personalized therapeutic strategy?]. |
NOTCH2 |
| 63 |
25311243 |
10.1038/leu.2014.302 |
2015 |
A microRNA-mediated regulatory loop modulates NOTCH and MYC oncogenic signals in B- and T-cell malignancies. |
NOTCH2 |
| 64 |
25355291 |
10.1093/carcin/bgu223 |
2015 |
DLL4 regulates NOTCH signaling and growth of T acute lymphoblastic leukemia cells in NOD/SCID mice. |
NOTCH2 |
| 65 |
25381127 |
10.3324/haematol.2014.116855 |
2015 |
The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection. |
NOTCH2 |
| 66 |
25428260 |
10.1038/leu.2014.330 |
2015 |
KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype. |
NOTCH2 |
| 67 |
25595890 |
10.18632/oncotarget.2218 |
2015 |
Mutational spectrum of adult T-ALL. |
NOTCH2 |
| 68 |
25612624 |
10.1182/blood-2014-08-596247 |
2015 |
DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features. |
NOTCH2 |
| 69 |
25663545 |
10.1007/s10549-015-3279-5 |
2015 |
The role of polycomb group protein Bmi-1 and Notch4 in breast cancer stem cell inhibition by benzyl isothiocyanate. |
NOTCH2 |
| 70 |
25779943 |
10.1158/1078-0432.CCR-14-2759 |
2015 |
Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing. |
NOTCH2 |
| 71 |
26498442 |
10.1186/s12885-015-1766-z |
2015 |
Whole exome sequencing of microdissected splenic marginal zone lymphoma: a study to discover novel tumor-specific mutations. |
NOTCH2 |
| 72 |
24116381 |
10.1111/bph.12442 |
2014 |
Involvement of midkine in neuroblastoma tumourigenesis. |
NOTCH2 |
| 73 |
24317268 |
10.1292/jvms.13-0344 |
2014 |
Notch2 transduction by feline leukemia virus in a naturally infected cat. |
NOTCH2 |
| 74 |
24651005 |
10.1016/j.ccr.2014.03.001 |
2014 |
A jagged road to lymphoma aggressiveness. |
NOTCH2 |
| 75 |
24651014 |
10.1016/j.ccr.2014.02.005 |
2014 |
Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance. |
NOTCH2 |
| 76 |
24689848 |
10.1111/cas.12408 |
2014 |
Disease-specific mutations in mature lymphoid neoplasms: recent advances. |
NOTCH2 |
| 77 |
24722428 |
10.1038/nrc3730 |
2014 |
Microenvironment: Endothelial cells create a niche. |
NOTCH2 |
| 78 |
25088352 |
10.1111/bjh.13052 |
2014 |
Molecular lesions of signalling pathway genes in clonal B-cell lymphocytosis with marginal zone features. |
NOTCH2 |
| 79 |
25141821 |
10.1002/path.4428 |
2014 |
Recurrent mutations of NOTCH genes in follicular lymphoma identify a distinctive subset of tumours. |
NOTCH2 |
| 80 |
25314575 |
10.1371/journal.pone.0108747 |
2014 |
The truncate mutation of Notch2 enhances cell proliferation through activating the NF-κB signal pathway in the diffuse large B-cell lymphomas. |
NOTCH2 |
| 81 |
23359069 |
10.1084/jem.20121527 |
2013 |
Notch activation inhibits AML growth and survival: a potential therapeutic approach. |
NOTCH2 |
| 82 |
23625998 |
10.1093/jb/mvt035 |
2013 |
The heparin-binding growth factor midkine: the biological activities and candidate receptors. |
NOTCH2 |
| 83 |
23665546 |
10.1016/j.semcancer.2013.04.002 |
2013 |
Genetic aberrations of signaling pathways in lymphomagenesis: revelations from next generation sequencing studies. |
NOTCH2 |
| 84 |
24145436 |
10.1073/pnas.1314608110 |
2013 |
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. |
NOTCH2 |
| 85 |
24168526 |
10.1586/17474086.2013.845522 |
2013 |
Splenic marginal zone lymphoma: disease features and management. |
NOTCH2 |
| 86 |
24349473 |
10.1371/journal.pone.0083244 |
2013 |
Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma. |
NOTCH2 |
| 87 |
22391171 |
|
2012 |
[Expression of Notch signal molecules in human lymphoma cells and its significance]. |
NOTCH2 |
| 88 |
22695918 |
10.1007/82_2012_235 |
2012 |
Notch2 and immune function. |
NOTCH2 |
| 89 |
22891273 |
10.1084/jem.20120904 |
2012 |
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development. |
NOTCH2 |
| 90 |
22891276 |
10.1084/jem.20120910 |
2012 |
Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma. |
NOTCH2 |
| 91 |
23022380 |
10.1016/j.molcel.2012.08.022 |
2012 |
NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function. |
NOTCH2 |
| 92 |
21332343 |
10.3109/0886022X.2011.553979 |
2011 |
Notch2/Hes-1 pathway plays an important role in renal ischemia and reperfusion injury-associated inflammation and apoptosis and the γ-secretase inhibitor DAPT has a nephroprotective effect. |
NOTCH2 |
| 93 |
21494254 |
10.1038/leu.2011.50 |
2011 |
GSI-I (Z-LLNle-CHO) inhibits γ-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemia. |
NOTCH2 |
| 94 |
22006338 |
10.1073/pnas.1114669108 |
2011 |
Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. |
NOTCH2 |
| 95 |
22128846 |
10.1186/1471-2407-11-502 |
2011 |
Current views on the role of Notch signaling and the pathogenesis of human leukemia. |
NOTCH2 |
| 96 |
20393564 |
10.1038/nature08878 |
2010 |
Therapeutic antibody targeting of individual Notch receptors. |
NOTCH2 |
| 97 |
20538790 |
10.1182/blood-2009-12-260216 |
2010 |
Notch1 as a potential therapeutic target in cutaneous T-cell lymphoma. |
NOTCH2 |
| 98 |
19001083 |
10.1182/blood-2008-03-147967 |
2009 |
Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases. |
NOTCH2 |
| 99 |
19075186 |
10.1182/blood-2008-08-174748 |
2009 |
Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL. |
NOTCH2 |
| 100 |
19339697 |
10.1182/blood-2008-11-190090 |
2009 |
Notch1, Notch2, and Epstein-Barr virus-encoded nuclear antigen 2 signaling differentially affects proliferation and survival of Epstein-Barr virus-infected B cells. |
NOTCH2 |
Datasets
Models
